
Our CRISPR webinar on May 14 brought way more questions than we were able to answer without keeping participants there all day, but many were too good to pass up.
Here are a few we thought would be interesting to a broad audience:
Our CRISPR webinar on May 14 brought way more questions than we were able to answer without keeping participants there all day, but many were too good to pass up.
Here are a few we thought would be interesting to a broad audience:
advertisement